Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2026-08-17 12:18:22 ET · period of report 2026-08-13 · accession 0000724004-26-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-17 12:18 | 2026-08-13 | MLAB | Sullivan John James | Dir | S - Sale | $112.80 | -7,093 | 17.8K | -28% | -$800.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-13 | S | D | 7,093 | $112.80 | 17,834 | D | — | — | (F1) Represents shares sold directly in a private transaction to Siddhartha Kadia, Mesa President and CEO |